Renal Research Institute

Closed portfolio with an early-phase archive tilt

According to ClinicalTrials.gov-derived indexes, Renal Research Institute sits in the top decile of US sponsors by registered trial count (#987 of 15,742 sponsors by registered trial count).

14 total trials none currently recruiting 11 completed early-phase tilt top decile by trial count

Renal Research Institute: 14 sponsored US clinical trials, none currently recruiting.

Renal Research Institute sponsors 14 registered US clinical trials on ClinicalTrials.gov, none currently recruiting, and 11 completed. 0 of these trials are in Phase 3-4 (later-stage) and 1 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is End Stage Renal Disease, with 2 trials.

Top-decile sponsor footprint

Renal Research Institute ranks in the top decile of sponsors by registered trial count (#987 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.

Trial completion reliability score

F 36/100

11 of 14 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (78.6%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.

Indexed trials (enrollment closed)

14 total, page 1 of 1

COMPLETED

Hemodialysis Vascular Access Imaging Study

NCT02374762
COMPLETED

A Comparison of Physical Activity Levels With and Without Feedback Via Fitbit® Flex™ in Hemodialysis Patients

NCT02320513
COMPLETED

Oxygen Desaturation During Hemodialysis

NCT02501044
TERMINATED

Sorbent Treatment Prescriptions Pilot Study

NCT01437761
TERMINATED

Comparison of Body Hydration State in Hemodialysis Patients

NCT01814254
COMPLETED

Effects of Simple Sodium Alignment on Clinical Outcomes

NCT01825590
COMPLETED NA

Effect of Sodium Concentration of Priming and Rinsing Fluids on Weight Gain

NCT01168947
COMPLETED NA

Comparison Study of Daily Ultrafiltration and Twice-weekly Hemodialysis

NCT00825318
TERMINATED

Red Blood Cell Lifespan

NCT01462071
COMPLETED NA

Comparison of Different Glucose Concentrations in Dialysate of Hemodialysis Patients

NCT00618033
COMPLETED Phase 2

Immune Effects of Vitamin D in Hemodialysis Patients

NCT00686751
COMPLETED

Are we Loading Our Patients With Sodium During Hemodialysis Treatments?

NCT01454193
COMPLETED

Events Before Death

NCT01329055
COMPLETED

Blood Pressure Change and Outcome

NCT01330004

Phase Distribution

PhaseTrial count
Phase 2 1

Therapeutic Areas

End Stage Renal Disease 2
Hemodialysis Fistula Thrombosis 1
Fistula 1
Hemodialysis 1
ESRD 1
Chronic Kidney Disease 1

How the Renal Research Institute early-phase archive is shaped

14 indexed studies, none listed as recruiting (0% open); 11 completed (79%).

Phase mix: 0 late (III/IV) vs 1 early (I/II) (early-phase heavy).

Top condition: End Stage Renal Disease (2 trials), 5 others listed.

How to read a closed sponsor archive

When recruiting_count is zero, the indexed set is completed or otherwise not open. Phase tilt still describes where archived studies sat on the investigational pathway. Re-check ClinicalTrials.gov before acting.

Renal Research Institute: archived-pipeline peers nationwide

Peers matched on 14 indexed studies with no current recruiting: volume and archive shape, not condition overlap.

Renal Research Institute sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot). 2×2 strategic matrix plotting 9 entities by Total trials (X) and Recruiting share (Y), with a crosshair dividing the plot into four quadrants. Higher volume & more openFocused & more openHigher volume, mostly closedSmaller & mostly closed 051015 0%0.0%0.0%0.1% Total trials Recruiting share Renal Research Institute3-C Institute for Social DevelopmentAbbott Medical OpticsAbbott RDx CardiometabolicAcceleron Pharma, Inc., a wholly-owned subsidiary of Merck & Co., Inc., Rahway, NJ USA10xBio22nd Century Group23andMe3 Waves Wellness
Renal Research Institute sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot).

Renal Research Institute sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.

Sponsors near 14 archived trials

Sponsors with similar archive density (± trial count)

Related

Read our methodology - how this data is sourced, computed, and verified.

What to do with this Renal Research Institute page

14 registered trials is a research-attention snapshot, not an endorsement of Renal Research Institute or any single study.

  • None of Renal Research Institute's trials are currently recruiting in this registry; that can change as new trials post, or check the broader research index. Browse research indexes
  • End Stage Renal Disease is the condition Renal Research Institute studies most, compare against other sponsors active in the same condition before evaluating a specific study. See End Stage Renal Disease trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Renal Research Institute pipeline card: 14 registered trials from official public datasets.Report a data error.